Related Experiment Video
Updated: Mar 26, 2026
07:43
In Vivo Quantification of Hip Arthrokinematics during Dynamic Weight-bearing Activities using Dual Fluoroscopy
Published on: July 2, 2021
3.7K
Advances and challenges in hemophilic arthropathy
Tine Wyseure1, Laurent O Mosnier1, Annette von Drygalski2
1The Scripps Research Institute, Department of Molecular and Experimental Medicine, La Jolla, CA, USA.
Seminars in Hematology
|January 26, 2016
Summary
Hemophilic arthropathy, a joint disease from bleeding, causes significant disability. Understanding its molecular mechanisms and developing advanced diagnostics like ultrasound are crucial for better treatment.
Area of Science:
- Orthopedics
- Rheumatology
- Hematology
Background:
- Hemophilic arthropathy is a joint disease secondary to joint bleeding.
- It involves synovial hypertrophy, cartilage, and bony destruction, often disabling in aging populations.
- Pathobiological changes are triggered by hemoglobin and iron deposition, but mechanisms are poorly understood.
Purpose of the Study:
- To review current understanding of hemophilic arthropathy's pathobiology.
- To explore advancements in diagnostic tools, including imaging and biomarkers.
- To highlight the need for better diagnostic and therapeutic strategies.
Main Methods:
- Review of current literature on hemophilic arthropathy.
- Discussion of advanced imaging techniques, specifically high-resolution musculoskeletal ultrasound with power Doppler.
- Exploration of potential diagnostic biomarkers.
Main Results:
- Current treatment options beyond clotting factor replacement are limited.
- High-resolution musculoskeletal ultrasound shows promise for point-of-care diagnosis and management.
- Diagnostic biomarkers could aid in identifying pain causes and predicting disease progression.
Conclusions:
- Improved understanding of pathobiology and development of sensitive diagnostics are essential for hemophilic arthropathy.
- Advanced imaging and biomarkers can facilitate early detection and management.
- Further research is needed to identify molecular mechanisms and develop targeted therapies.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
840
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
840
01:21Rheumatic Heart Disease III: Medical Management
487
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
487
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:26Atherosclerosis III: Management
578
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
578
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K